REDICARE BLOOD CLOTTING- blood clotting spray aerosol, spray 
Redicare LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Blood Clotting Spray

Active Ingredients

Benzethonium Chloride 0.2% w/w

Lidocaine 4% w/w

Purpose

Topical Antiseptic

Topical Antiseptic

Uses

WARNINGS

For external use only.

Flammable

DO NOT USE

  • in eyes or other mucous membranes
  • on large portions of the body
  • in case of deep or puncture wounds
  • on raw surfaces
  • on blistered areas
  • on animal bites
  • on serious burns

DO NOT USE

  • in eyes or other mucous membranes
  • on large portions of the body
  • in case of deep or puncture wounds
  • on raw surfaces
  • on blistered areas
  • on animal bites
  • on serious burns

Stop use and ask doctor if:

  • Redness, swelling, or irritation occurs
  • Infection occurs
  • The condition persists or worsens
  • Symptoms persist for more than 7 days

Stop use and ask doctor if:

  • Redness, swelling, or irritation occurs
  • Infection occurs
  • The condition persists or worsens
  • Symptoms persist for more than 7 days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive Ingredients

Isobutane, Isopropyl Myristate, Karaya, N-Butane, Propane, Silica, Silicone, Sorbitan Monooleate, Talc, Tragacanth

Principal Display

REDICARE BLOOD CLOTTING 
blood clotting spray aerosol, spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71105-107
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP) BENZETHONIUM CHLORIDE170 mg  in 85 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE3400 mg  in 85 g
Inactive Ingredients
Ingredient NameStrength
PROPANE (UNII: T75W9911L6)  
3-(TRIETHOXYSILYL)PROPYLAMINE (UNII: L8S6UBW552)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
TALC (UNII: 7SEV7J4R1U)  
ISOBUTANE (UNII: BXR49TP611)  
BUTANE (UNII: 6LV4FOR43R)  
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)  
KARAYA GUM (UNII: 73W9IQY50Q)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TRAGACANTH (UNII: 2944357O2O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71105-107-0385 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product10/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34810/01/2023
Labeler - Redicare LLC (800149346)
Registrant - Redicare LLC (800149346)

Revised: 9/2023
Document Id: 064649c9-cf69-a4c3-e063-6294a90a3624
Set id: 064649c9-cf68-a4c3-e063-6294a90a3624
Version: 1
Effective Time: 20230926
 
Redicare LLC